Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
about
Phase 2 study of CHOP-R-14 followed by 90Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@en
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@nl
type
label
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@en
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@en
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1476
Phase 2 study of CHOP-R-14 fol ...... diffuse large B-cell lymphoma.
@en
P2093
Jamile M Shammo
Melissa L Larson
Parameswaran Venugopal
Reem Karmali
Stephanie A Gregory
Teresa O'Brien
P2860
P304
P356
10.3892/MCO.2017.1169
P577
2017-02-17T00:00:00Z